Kiyohisa KAMIMURA | Neuroscience | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Kiyohisa KAMIMURA | Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Kiyohisa KAMIMURA, Kagoshima University Graduate School of Medical and Dental Sciences, Japan

Dr. Kiyohisa Kamimura is a renowned radiologist and Specially Appointed Associate Professor at the Department of Advanced Radiological Imaging, Kagoshima University, Japan. He holds an M.D. and Ph.D. from Kagoshima University, with over two decades of experience in radiology, including leadership roles such as Chief Radiologist at Kirishima Medical Center. Dr. Kamimura is a board-certified member of multiple prestigious radiology societies, specializing in advanced imaging techniques. His active research collaborations with Shin Nippon Biomedical Laboratories (SNBL) highlight his commitment to medical innovation. He is recognized for his expertise in neuroradiology and magnetic resonance imaging. πŸŒŸπŸ“‘

 

Publication Profile

Orcid

Education Journey

Dr. Kiyohisa Kamimura pursued his extensive medical education at Kagoshima University, Japan. He began with a premedical program (1992–1994) before advancing to an undergraduate degree in medicine (1994–1998). He further honed his expertise by completing an M.D. and Ph.D. at Kagoshima University Graduate School of Medical and Dental Science (2000–2008). His academic journey reflects a steadfast dedication to medical excellence and radiological research, laying the foundation for his impactful career in advanced imaging and radiology. πŸ©ΊπŸ“–

 

Professional Experience

Dr. Kiyohisa Kamimura has an illustrious career in radiology spanning over two decades. Starting at Kagoshima University Medical and Dental Hospital (1998–2000), he worked at several esteemed institutions, including Kagoshima Prefectural Oshima Hospital and Nanpuh Hospital. He served as Chief Radiologist at Kirishima Medical Center (2013–2014) and Assistant Professor at Kagoshima University (2014–2023). Currently, he is a Specially Appointed Associate Professor in the Department of Advanced Radiological Imaging at Kagoshima University. His roles demonstrate expertise in radiology and a commitment to advancing medical imaging technologies. πŸŒŸπŸ“‘

 

Research Focus

Dr. Kiyohisa Kamimura specializes in advanced radiological imaging, with a focus on brain and tumor imaging. His research includes time-dependent MRI diffusion for differentiating pituitary tumors, glioblastomas, brain metastases, and primary CNS lymphomas. He also explores MR amide proton transfer imaging and dynamic contrast-enhanced MRI for tumor evaluation. Dr. Kamimura’s work contributes significantly to neuroimaging, oncology diagnostics, and imaging biomarkers. His expertise extends to pancreatic ductal adenocarcinoma imaging and intravoxel incoherent motion studies in the pituitary gland, advancing precision diagnostics and treatment planning. πŸŒŸπŸ©ΊπŸ“ˆ

 

Publication Top NotesΒ πŸ“š

 

  • Time‐dependent MR diffusion analysis of functioning and nonfunctioning pituitary adenomas/pituitary neuroendocrine tumors (2025) – DOI: 10.1111/jon.13254 πŸ§ πŸ“…
  • Differentiating primary CNS lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient (2023) – DOI: 10.1186/s40644-023-00639-7 πŸ§ πŸ“ˆ
  • Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI (2023) – DOI: 10.1186/s40644-023-00595-2 πŸ§ πŸ”
  • Differentiation of hemangioblastoma from brain metastasis using MR amide proton transfer imaging (2022) – DOI: 10.1111/jon.13019 πŸ©»πŸ”¬
  • Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI (2021) – DOI: 10.3390/cancers13153914 🧠⚑
  • Visual enhancement pattern during the delayed phase of enhanced CT as a prognostic factor in stage IV pancreatic ductal adenocarcinoma (2020) – DOI: 10.1016/j.pan.2020.07.009 🩺✨
  • Large Intraosseous Schwannoma in Petrous Apex Presenting with Intratumoral Hemorrhage (2019) – DOI: 10.1016/j.wneu.2019.07.179 🦴🩹
  • Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions (2019) – DOI: 10.1007/s11604-018-0787-3 πŸ”πŸ’‘
  • Intravoxel Incoherent Motion in Normal Pituitary Gland: Initial Study with Turbo Spin-Echo Diffusion-Weighted Imaging (2016) – DOI: 10.3174/ajnr.A4930 πŸ§ πŸŒ€
  • Contrast-enhanced CT and diffusion-weighted MR imaging as prognostic factors in pancreatic ductal adenocarcinoma (2014) – DOI: 10.1016/j.ejrad.2013.12.016 πŸ©»πŸ“Š

 

Lin Yuan | Neuroscience | Best Researcher Award

Posted on by ScienceFather

Lin Yuan | Neuroscience | Best Researcher Award

Prof Dr Lin Yuan, Peking University Shenzhen Hospital, China

Prof. Dr. Lin Yuan: Evaluation for Best Researcher Award.

Publication profile

Scopus

Positions and Experience

Prof. Dr. Lin Yuan is currently a Professor at the Institute of Biomedical Sciences, Peking University Shenzhen Hospital, China (since March 2021). His previous roles include serving as an Associate Professor at the Systems Biomedicine Research Institute, Peking University, from 2015 to 2017. His academic journey is bolstered by his Ph.D. and M.Sc. in Biochemistry and Molecular Biology from the Chinese People’s Liberation Army Academy of Military Medical Sciences. Additionally, he has gained valuable research experience as a Postdoctoral Fellow at UT Southwestern Medical Center (2017-2020).

Research Grants and Projects

Prof. Yuan has been actively involved in prestigious research projects funded by the National Natural Science Foundation of China (NSFC). His notable projects include studying the tumor microenvironment’s role in breast cancer progression and drug resistance, as well as exploring the regulation of p53 in lipid metabolism. His work has also focused on deubiquitinases for the tumor suppressor PTEN and its protein stability, highlighting his commitment to understanding tumorigenesis mechanisms.

Awards and Honors

Prof. Yuan’s research excellence has been recognized through various accolades. Noteworthy among these are the Outstanding Scientific Research Award from UT Southwestern Medical Center in 2020 and the First Prize of the Beijing Municipal Science and Technology Progress Award in 2017 for his research on protein homeostasis regulation. These honors underscore his contributions to advancing biomedical research.

Publications and Impact

Prof. Yuan’s research findings have been published in high-impact journals, showcasing his contributions to cancer biology, neurodegenerative diseases, and molecular biology. His work on mitochondrial regulation as a potential Alzheimer’s therapy, chemoresistance mechanisms in colorectal cancer, and neural stem cell differentiation through signaling pathways is evidence of his expertise and versatility. His publications have received citations, reflecting the academic and clinical relevance of his research.

Conclusion

Given his significant academic background, successful acquisition of competitive research grants, impactful publications, and prestigious awards, Prof. Dr. Lin Yuan is a strong candidate for the Best Researcher Award. His work not only advances scientific understanding but also contributes to developing innovative therapeutic approaches, particularly in oncology and neurobiology. Prof. Yuan’s commitment to excellence in research and his demonstrated ability to lead high-impact projects make him well-suited for recognition as a top researcher.

Publication top notes

Regulating Lars2 in mitochondria: A potential Alzheimer’s therapy by inhibiting tau phosphorylation

mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer

Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer

HIF-1Ξ± Affects the Neural Stem Cell Differentiation of Human Induced Pluripotent Stem Cells via MFN2-Mediated Wnt/Ξ²-Catenin Signaling

PPP2R1B is modulated by ubiquitination and is essential for spermatogenesis

Downregulated hsa_circ_0036988 promotes proliferation and metastasis in oral squamous cell carcinoma